PROIncyte Corp
stock111.36
-1.43 (-1.27%)
Price as of 13 Oct, 15:50 · Rate limit reached. Please try again in a minute.
Good Money Guide Pro Score
Weak
Weak investment profile
Technical Analysis
Short-Term Outlook
Bullish
3 bull · 2 bear · 0 neutral
Medium-Term Outlook
Bearish
1 bull · 3 bear · 0 neutral
Price below 50-day MA
Price above 200-day MA
Price below 12-day EMA
Price below 26-day EMA
Oversold — potential reversal up
MACD below signal line
Oversold — potential reversal up
Price near lower band — potential bounce
Volatility measure — informational only
Volume Indicators
On Balance Volume (OBV)
Volume Accumulation Distribution (VAD)
Market Statistics
Day Change
-1.43
Market Cap
23424459000
Exchange
NASDAQ
Sector
Health Care
Fundamentals
Rate limit reached. Please try again in a minute.
Analyst Forecast
Rate limit reached. Please try again in a minute.
Fundamental Analysis
Unable to load fundamental data
Learn about Incyte Corp
What is Incyte Corp?
Incyte Corporation is a biopharmaceutical company that focuses on discovering, developing, and manufacturing proprietary therapeutics to treat serious medical conditions, particularly in oncology and inflammation. They are best known for their work in myeloproliferative neoplasms and dermatology, often bringing targeted treatments to market through both internal research and strategic partnerships. Essentially, they act as a scientific engine that seeks to improve patient outcomes by addressing unmet clinical needs.
Is Incyte Corp a good investment?
Incyte offers potential for growth due to a strong pipeline of innovative drugs and consistent revenue from its flagship products, but investors must consider the inherent risks of clinical trial failures and high competition in the biotech sector. Stock performance can be volatile depending on FDA approval cycles and patent expirations, which are common challenges for any pharmaceutical company. Please remember that this information is for educational purposes only and does not constitute professional financial advice.
How do you invest in Incyte Corp?
You can gain exposure to Incyte Corp by purchasing individual shares through a regulated brokerage platform that provides access to the Nasdaq stock exchange. Alternatively, if you prefer a diversified approach, you can invest in healthcare-focused exchange-traded funds or mutual funds that include INCY among their holdings. Ensure you use a reputable broker and conduct your own due diligence before executing any trades.
Educational content generated by AI — not financial advice.
Time & Sales
No trades yet.
News & Sentiment
Rate limit reached. Please try again in a minute.
Community Discussion
No posts yet for INCY — be the first to start the discussion.
Point & Figure Analysis
OHLC
Signals
as of 07 Oct 2026Targets
Famous Investors Holding INCY
Jim Simons
3.51M sh · 0.5% of portfolio
$398.14M
NEW
Ray Dalio
168.3K sh · 0.1% of portfolio
$19.07M
NEW
Ken Fisher
137.0K sh · 0.0% of portfolio
$15.53M
NEW
Ken Griffin
103.8K sh · 0.0% of portfolio
$11.77M
NEW
Ken Griffin
102.4K sh · 0.0% of portfolio
$11.61M
NEW
Ken Griffin
52.1K sh · 0.0% of portfolio
$5.91M
NEW
Ken Griffin
39.7K sh · 0.0% of portfolio
$4.50M
NEW
Source: SEC Form 13F, reporting period 30 Jun 2026. 45-day lag applies.